Last reviewed · How we verify

NCT03477318

Accuracy of Endoscopists in Predicting Polyp Pathology

Completed Last updated 14 June 2019
What this trial tests

trial in Resected Polyp in 159 participants. Completed in 7 November 2018.

Timeline
20 March 2018
Primary endpoint
7 November 2018
7 November 2018

Quick facts

Lead sponsorTriHealth Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment159
Start date20 March 2018
Primary completion7 November 2018
Estimated completion7 November 2018
Sites1 location across United States

Conditions studied

Sponsor

TriHealth Inc. — full company profile →

Who can join

50 and older, any sex, with Resected Polyp. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study purpose is to assess the accuracy of experienced endoscopists at a community hospital in predicting histological types of polyps resected at colonoscopy using white light. Patients 50 years or older undergoing first-time screening colonoscopy will be included in this observational study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other TriHealth Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03477318.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing